Regencell Bioscience(US:RGC) 智通财经网·2026-01-05 14:13Core Viewpoint - Brain Rejuvenation Technology (RGC.US) experienced a pre-market surge of over 21%, reaching $25.04, driven by Elon Musk's announcement regarding mass production, which catalyzed a significant rally in the brain-computer interface sector [1] Industry Summary - The A-share and Hong Kong stock markets saw the brain-computer interface sector rise by 13% and 12% respectively, indicating strong market interest [1] - The relationship between Brain Rejuvenation Technology and brain-computer interfaces can be understood as an upstream and downstream connection in the medical field, where "repairing hardware" and "establishing connections" are interlinked [1] - The popularity of brain-computer interface concepts in the market has led to a chain reaction, causing the associated brain rejuvenation technologies to benefit from the overarching narrative of "brain technology" [1]